Under GST law,
the concept of “composite supply”
is still an area of interpretation even
though the government has issued clarifications and FAQs as unique
underlying facts of each case needs to be examined. One
such scenario relates
to the Reagent Rental Contract (“RRC”) which is commonly
entered into by the medical
device companies with hospitals, laboratories etc.
Under this model, the medical instruments are provided
by the companies without any consideration for a specified period to the end customers
such as hospital, laboratories etc., who
in return agrees
to purchase a minimum quantity
of reagents/consumable during
the contract period at agreed
prices. Also, the reagents are procured through their authorised distributor
channels.
The modus operandi
of the transaction under this model is that the movement of the medical instruments are done on the basis
of a delivery challan and the reagents/consumables are supplied at specified prices
by way of issuing a tax invoice
at applicable rate of GST.
With the market
players extensively operating under such business
model and the
GST regime still being
in its evolving phase, the tax implications arising on such transactions is yet to attain
uniformity. As we understand that, in case businesses perceives any doubts, they can opt to
approach the Authority of Advance
Ruling to determine the tax consequences of the particular transaction.
In one such instance, the above transaction was examined
by the Kerala Advance Ruling Authority (‘Kerala AAR’) in the case of M/s Abbott
Healthcare (P.) Ltd. (“company”) [TS-538- AAR-2018-NT], wherein
it was held
that above transaction of placing the medical instruments to unrelated customers like hospitals/laboratories for their use without any consideration, in the
backdrop of an agreement containing minimum purchase obligation of products like
reagents/consumables for a specified period
constituted “composite supply”.
Aggrieved by the above ruling the company
filed an appeal before the Appellate Authority
for Advance Ruling (AAAR)
[TS-917-AAAR-2018-NT] who rejected the appeal of the company
and hence a writ was filed before the Kerala High Court [TS-4-HC-2020(KER)-NT].
In the ensuing
part of this
article, effort has been made
to highlight the
key aspects pronounced by Hon’ble High Court of Kerala.
Brief Facts of the Case








The Kerala
High Court Decision
Context
The High Court stated that the AAR had opined that the
company had made two supplies, namely of medical instruments and of
reagents/consumables to be used along with the instruments. Since the instruments supplied
had no utility to the customer unless
he also bought the reagents/consumables, the supply
of the instruments and reagents/consumables had to be seen as naturally bundled to form a
composite supply. The AAR went on to observe that the
supply of instrument was to be treated as principal
supply, in the composite supply, and accordingly, that the reagents etc had to
taxed at a higher rate applicable to the instrument supplied. As regards valuation of the said
supply, the AAR found that
in terms of the agreement, the company had, in fact,
supplied the medical instrument for deferred consideration since, according to
it, the minimum purchase obligation in respect of reagents etc, under the
agreement, ensured that
the overall price
realized from customer subsumed within it,
the rent for the
instrument as well.
This was more so because,
the agreement between
the parties clearly stipulated that if the required quantity
of reagents was not purchased
by the customer, it was obliged to pay to the company
the deficient amount.
The aforesaid findings of AAR were
upheld by the AAAR.
Observations



It will be apt at this stage
to reproduce the
definition of “ composite supply”
under the GST Act:
“ a supply
made by a
taxable person to a recipient consisting of two or more
taxable supplies of goods
or services or both, or any combination thereof, which are naturally bundled
and supplied in conjunction with each other
in the ordinary course of business, one of which
is the principal supply”.
The High Court held that in order for the supply to be
composite, it has to be made by one taxable person. In the instant
case, the instrument is provided by company and the supply
of reagents/consumables by the distributors who purchase it from the company on a principal to principal basis. Although
it could be argued that
there is a relationship between
the said persons that influences the valuation
of the supply, the same does not take away from the fact that the
supplies are, in reality made
by two different taxable persons.
Indeed supplies by two separate suppliers could not be treated as principal and ancillary supplies.
The High Court
also held that
composite supply must
take into account
supplies as effected at a given point in
time on “ as is where is “ basis.

Key Takeaways
from the Decision



Reagent
Rental Contract
It is important to mention that recently there has been a Karnataka
AAR in the case ofM/s Randox
Laboratories India Private Limited [TS-1025-AAR-2019-NT] on facts which are
identical to the facts of the case
of M/s Abbott Healthcare Pvt.
Ltd. The Karnataka AAR held that there will be no tax implication arising on medical
instrument provided to the hospital where no
consideration was received, as the same is outside the purview of supply under
GST. Conclusion
It is interesting to note that
the Hon’ble High
Court has remanded
the matter back
to Kerala AAR for
fresh consideration based on the observations made in the judgment.
Unless challenged in the higher
fora, the said order would provide major relief to the medical device industry, which might
have faced a major impact
in case the of supply
under RRC model, as the entire supply
would have resulted
in levy of tax @ 18% (taking
instruments as a principal
supply) instead of 5%/12% as applicable on the supply of reagents.
Now, it would be interesting to see how the outcome
of the matter after the observations made by
the High Court
of Kerala, whether
the same would
concur with the ruling pronounced by the Karnataka AAR
as in the case of M/s Randox
Laboratories India Private
Limited or would
lead to another round of litigation
A favorable ruling may result in putting rest to a lot of future
litigations on the said matter.
No comments:
Post a Comment